Ashton Thomas Private Wealth LLC Buys 9,193 Shares of Sabra Health Care REIT, Inc. (NASDAQ:SBRA)

Ashton Thomas Private Wealth LLC increased its position in Sabra Health Care REIT, Inc. (NASDAQ:SBRA) by 835.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,293 shares of the real estate investment trust’s stock after buying an additional 9,193 shares during the quarter. Ashton Thomas Private Wealth LLC’s holdings in Sabra Health Care REIT were worth $192,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Sei Investments Co. grew its holdings in Sabra Health Care REIT by 1.4% during the 1st quarter. Sei Investments Co. now owns 109,558 shares of the real estate investment trust’s stock worth $1,618,000 after acquiring an additional 1,469 shares during the period. US Bancorp DE increased its holdings in Sabra Health Care REIT by 8.3% during the 1st quarter. US Bancorp DE now owns 22,412 shares of the real estate investment trust’s stock worth $331,000 after purchasing an additional 1,713 shares in the last quarter. ProShare Advisors LLC raised its position in Sabra Health Care REIT by 4.7% in the 1st quarter. ProShare Advisors LLC now owns 52,900 shares of the real estate investment trust’s stock valued at $781,000 after buying an additional 2,393 shares during the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. raised its holdings in shares of Sabra Health Care REIT by 63.6% in the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 318,808 shares of the real estate investment trust’s stock valued at $4,709,000 after purchasing an additional 123,966 shares during the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. increased its stake in Sabra Health Care REIT by 3.1% in the 1st quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 140,855 shares of the real estate investment trust’s stock valued at $2,080,000 after buying an additional 4,188 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Health Care REIT Price Performance

Shares of Sabra Health Care REIT stock opened at $18.18 on Friday. The stock has a market capitalization of $4.30 billion, a price-to-earnings ratio of 44.34, a price-to-earnings-growth ratio of 2.35 and a beta of 1.25. The company has a fifty day moving average of $18.60 and a 200-day moving average of $16.54. Sabra Health Care REIT, Inc. has a 52-week low of $12.83 and a 52-week high of $20.03. The company has a debt-to-equity ratio of 0.90, a quick ratio of 4.16 and a current ratio of 4.16.

Sabra Health Care REIT (NASDAQ:SBRA) last issued its earnings results on Thursday, October 31st. The real estate investment trust reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.35 by ($0.22). The company had revenue of $178.00 million for the quarter, compared to analysts’ expectations of $177.19 million. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. During the same quarter in the prior year, the company earned $0.34 earnings per share. Equities research analysts expect that Sabra Health Care REIT, Inc. will post 1.39 EPS for the current year.

Sabra Health Care REIT Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, November 29th. Shareholders of record on Friday, November 15th will be issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 6.60%. The ex-dividend date is Friday, November 15th. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 292.69%.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on SBRA. Truist Financial lifted their target price on Sabra Health Care REIT from $16.00 to $18.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Wells Fargo & Company upgraded Sabra Health Care REIT from an “equal weight” rating to an “overweight” rating and increased their target price for the stock from $16.00 to $20.00 in a research report on Tuesday, October 1st. Citigroup upgraded shares of Sabra Health Care REIT from a “neutral” rating to a “buy” rating and raised their price objective for the company from $17.00 to $20.00 in a research report on Friday, September 13th. Finally, Scotiabank boosted their price objective on Sabra Health Care REIT from $17.00 to $18.00 and gave the stock a “sector perform” rating in a report on Friday, October 11th. One investment analyst has rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $18.71.

Sabra Health Care REIT Company Profile

As of September 30, 2023, Sabra's investment portfolio included 377 real estate properties held for investment (consisting of (i) 240 Skilled Nursing/Transitional Care facilities, (ii) 43 senior housing communities (Senior Housing – Leased), (iii) 61 senior housing communities operated by third-party property managers pursuant to property management agreements (Senior Housing – Managed), (iv) 18 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), 12 investments in loans receivable (consisting of two mortgage loans and 10 other loans), five preferred equity investments and two investments in unconsolidated joint ventures.